Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

NCT04327661 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

366

Enrollment

INDUSTRY

Sponsor class

Conditions

Motion Sickness

Interventions

DRUG: Tradipitant
DRUG: Placebo

Sponsor

Vanda Pharmaceuticals